Investor Presentaiton

sanofi Ready to launch Beyfortus in the 2023 season Production is already underway Stakeholders fully engaged > Licensed in EU, Great Britain, Canada Broad population programs expected in Spain and France License, ACIP recommendation and VFC inclusion expected soon > Contracting and reimbursement underway Priority review granted 28 Vaccines Investor Event Beyforbus C

View entire presentation